ProfileGDS4718 / 1554638_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 32% 21% 18% 35% 26% 24% 24% 22% 29% 21% 19% 20% 9% 19% 13% 26% 22% 23% 15% 14% 28% 27% 26% 29% 23% 12% 44% 28% 38% 14% 11% 17% 22% 24% 39% 40% 11% 22% 27% 22% 21% 14% 26% 13% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.6222332
GSM549102patient 115, normal, homogenized [OPG study]4.2070221
GSM549104patient 119, normal, homogenized [OPG study]4.0591818
GSM549108patient 138, normal, homogenized [OPG study]4.8008235
GSM549119patient 077, normal, homogenized [OPG study]4.374326
GSM549133patient 032, cancer, homogenized [OPG study]4.2535524
GSM549139patient 042, cancer, homogenized [OPG study]4.263724
GSM549099patient 107, normal, homogenized [OPG study]4.2477922
GSM549109patient 139, normal, homogenized [OPG study]4.5185929
GSM549110patient 046, normal, homogenized [OPG study]4.1973721
GSM549114patient 063, normal, homogenized [OPG study]4.0672319
GSM549122patient 082, normal, homogenized [OPG study]4.1364320
GSM549134patient 033, cancer, homogenized [OPG study]3.738419
GSM549136patient 036, cancer, homogenized [OPG study]4.057219
GSM549140patient 044, cancer, homogenized [OPG study]3.8722713
GSM549111patient 047, normal, homogenized [OPG study]4.3421526
GSM549113patient 057, normal, homogenized [OPG study]4.172622
GSM549132patient 031, cancer, homogenized [OPG study]4.2325223
GSM549137patient 038, cancer, homogenized [OPG study]3.9595815
GSM549142patient 047, cancer, homogenized [OPG study]4.0055714
GSM549100patient 110, normal, homogenized [OPG study]4.4971228
GSM549107patient 135, normal, homogenized [OPG study]4.3837327
GSM549115patient 068, normal, homogenized [OPG study]4.3214126
GSM549116patient 072, normal, homogenized [OPG study]4.4742229
GSM549120patient 078, normal, homogenized [OPG study]4.2633523
GSM549131patient 030, cancer, homogenized [OPG study]3.8058712
GSM549118patient 074, normal, homogenized [OPG study]5.1671444
GSM549129patient 027, cancer, homogenized [OPG study]4.4652928
GSM549123patient 088, normal, homogenized [OPG study]4.8695338
GSM549124patient 006, cancer, homogenized [OPG study]3.9637614
GSM549126patient 015, cancer, homogenized [OPG study]3.8107911
GSM549128patient 025, cancer, homogenized [OPG study]3.9904417
GSM549103patient 117, normal, homogenized [OPG study]4.271722
GSM549117patient 073, normal, homogenized [OPG study]4.2787424
GSM549138patient 041, cancer, homogenized [OPG study]4.9378839
GSM549141patient 045, cancer, homogenized [OPG study]4.9408240
GSM549130patient 028, cancer, homogenized [OPG study]3.8226111
GSM549101patient 111, normal, homogenized [OPG study]4.2358922
GSM549105patient 128, normal, homogenized [OPG study]4.4421527
GSM549106patient 134, normal, homogenized [OPG study]4.1810422
GSM549112patient 048, normal, homogenized [OPG study]4.1926121
GSM549125patient 011, cancer, homogenized [OPG study]3.9393514
GSM549127patient 024, cancer, homogenized [OPG study]4.3438326
GSM549135patient 035, cancer, homogenized [OPG study]3.8481713